23034 Federal Register / Vol. 66, No. 88 / Monday, May 7, 2001 / Notices

Dated: April 24, 2001.

David W. Feigal, Jr.,

Director, Center for Devices and Radiological

Health.

[FR Doc. 01–11329 Filed 5–4–01; 8:45 am]

BILLING CODE 4160–01–S

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Submission for OMB Review;

Comment Request; Application for the

Pharmacology Research Associate

Program

SUMMARY: Under the provisions of

Section 3507(a)(1)(D) of the Paperwork

Reduction Act of 1995, the National

Institute of General Medical Sciences

(NIGMS), the National Institutes of

Health (NIH) has submitted to the Office

of Management and Budget (OMB) a

request to review and approve the

information collection listed below.

This proposed information collection

was previously published in the Federal

Register on February 6, 2001, pages

9089–9090, and allowed 60 days for

public comment. No public comments

were received. The purpose of this

notice is to allow an additional 30 days

for public comment. The National

Institutes of Health may not conduct or

sponsor, and the respondent is not

required to respond to, an information

collection that has been extended,

revised, or implemented on or after

October 1, 1995, unless it displays a

currently valid OMB control number.

Proposed Collection: Title:

Application for the Pharmacology

Research Associate Program. Type of

Information Collection Request:

Extension of a currently approved

collection. Need and Use of Information

Collection: The Pharmacology Research

Associate (PRAT) Program will use the

applicant and referee information to

award opportunities for training and

experience in laboratory or clinical

investigation to individuals with a PhD.

degree in pharmacology or a related

science, M.D., or other professional

degree through appointments as PRAT

Fellows at the National Institutes of

Health or the Food and Drug

Administration. The goal of the program

is to develop leaders in pharmacological

research for key positions in academic,

industrial, and Federal research

laboratories. Frequency of Response:

Once a year. Affected Public:

Individuals or households; Businesses

or other for-profit.

The annual reporting burden is as

follows:

Type and numbers of respondents

Estimated

number of

responses per

respondent

Estimated total

responses

Average

burden hours

per

responses

Estimated total

annual burden

hours requested

Applicants—50 ................................................................................................. 1 50 2.00 100

Referees—150 ................................................................................................. 1 150 0.167 25

Total Number of Respondents: 200

Total Number of Responses: 200

Total Hours: 125

The annualized cost to respondents is

estimated at:

Applicants: $5,500.00

Referees: $1,250.00

There are no Capital Costs, Operating

Costs, and/or Maintenance Costs to

report.

Request for Comments:

Written comments and/or suggestions

from the public and affected agencies

should address one or more of the

following points: (1) Evaluate whether

the proposed collection of information

is necessary for the proper performance

of the function of the agency, including

whether the information will have

practical utility; (2) Evaluate the

accuracy of the agency’s estimate of the

burden of the proposed collection of

information, including the validity of

the methodology and assumptions used;

(3) Enhance the quality, utility, and

clarity of the information to be

collected; and (4) Minimize the burden

of the collection of information on those

who are to respond, including the use

of appropriate automated, electronic,

mechanical or other technological

collection techniques or other forms of

information technology.

Direct Comments to OMB: Written

comments and/or suggestions regarding

the item(s) contained in this notice,

especially regarding the estimated

public burden and associated response

time, should be directed to the: Office

of Management and Budget, Office of

Regulatory Affairs, New Executive

Office Building, Room 10235,

Washington, D.C. 20503, Attention:

Desk Officer for NIH. To request more

information on the proposed project or

to obtain a copy of the data collection

plans and instruments, contact: Ms.

Sally Lee, NIGMS, NIH, Natcher

Building, Room 2AN–18H, 45 Center

Drive, MSC 6200, Bethesda, MD 20892–

6200. Phone (301) 594–2755, facsimile

(301) 402–0156, or electronic mail:

LeeS@nigms.nih.gov.

Comments Due Date:

Comments regarding this information

collection are best assured of having

their full effect if received within 30

days of the date of this publication.

Dated: April 30, 2001.

Martha Pine,

Associated Director for Administration and

Operations, National Institute of General

Medical Sciences.

[FR Doc. 01–11392 Filed 5–4–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Submission for OMB Review;

Comment Request; Case-Cohort Study

of Cancer and Related Disorders

Among Benzene-Exposed Workers in

China

SUMMARY: Under the provisions of

Section 3507(a)(1)(D) of the Paperwork

Reduction Act of 1995, the National

Cancer Institute (NCI), the National

Institutes of Health (NIH) has submitted

to the Office of Management and Budget

(OMB) a request for review and

approval of the information collection

listed below. This proposed information

collection was previously published in

the Federal Register on December 28,

2000, pages 82382–82383 and allowed

60 days for public comment. No public

comments were received. The purpose

of this notice is to allow an additional

30 days for public comment. The

National Institutes of Health may not

conduct or sponsor, and the respondent

is not required to respond to, an

information collection that has been

extended, revised, or implemented on or

after October 1, 1995, unless it displays

a currently valid OMB control number.

Proposed Collection: Title: CaseCohort (formerly Case-Control) Study of

Cancer and Related Disorders Among